BioSpace News Archive

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance function of Regulatory T Cells (Tregs) function, today announced its financial results for fiscal year ended December 31, 2022, and provided a clinical and business update.

Evolent Health, Inc., a health care company that delivers proven value-based specialty care solutions to payers and providers, announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation,.